A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder

References

• PolanczykGde LimaMSHortaBLBiedermanJRohdeLAThe worldwide prevalence of ADHD: a systematic review and metaregression analysisAm J Psychiatry2007164694294817541055
   PubMed Web of Science ®Google Scholar
• MontielCPenaJAMontiel‐BarberoIPolanczykGPrevalence rates of attention deficit/hyperactivity disorder in a school sample of Venezuelan childrenChild Psychiatry Hum Dev200839331132218157741
   PubMed Web of Science ®Google Scholar
• PolanczykGRohdeLAEpidemiology of attention‐deficit/hyperactivity disorder across the lifespanCurr Opin Psychiatry200720438639217551354
   PubMed Web of Science ®Google Scholar
• SimonVCzoborPBalintSMeszarosABitterIPrevalence and correlates of adult attention‐deficit hyperactivity disorder: meta‐analysisBr J Psychiatry2009194320421119252145
   PubMed Web of Science ®Google Scholar
• BarkleyRAGrodzinskyGDuPaulGJFrontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research reportJ Abnorm Child Psychol19922021631881593025
   PubMed Web of Science ®Google Scholar
• ClarkCPriorMKinsellaGJDo executive function deficits differentiate between adolescents with ADHD and oppositional defiant/conduct disorder? A neuropsychological study using the Six Elements Test and Hayling Sentence Completion TestJ Abnorm Child Psychol200028540341411100915
   PubMed Web of Science ®Google Scholar
• WeissGHechtmanLMilroyTPerlmanTPsychiatric status of hyperactives as adults: a controlled prospective 15‐year follow‐up of 63 hyperactive childrenJ Am Acad Child Psychiatry19852422112203989165
   PubMedGoogle Scholar
• DavidsonMAADHD in adults: a review of the literatureJ Atten Disord200811662864118094324
   PubMed Web of Science ®Google Scholar
• MordreMGroholtBSandstadBMyhreAMThe impact of ADHD symptoms and global impairment in childhood on working disability in mid‐adulthood: a 28‐year follow‐up study using official disability pension records in a high‐risk in‐patient populationBMC Psychiatry20121217423083209
   PubMed Web of Science ®Google Scholar
• DulcanMKBensonRSAACAP Official Action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHDJ Am Acad Child Adolesc Psychiatry1997369131113179291734
   PubMed Web of Science ®Google Scholar
• ArnstenAFStimulants: therapeutic actions in ADHDNeuropsychopharmacology200631112376238316855530
   PubMed Web of Science ®Google Scholar
• MohammadiMAkhondzadehSAdvances and considerations in attention‐deficit/hyperactivity disorder pharmacotherapyActa Medica Iranica201149848749822009816
   PubMedGoogle Scholar
• RoslerMFischerRAmmerROseCRetzWA randomised, placebo‐controlled, 24‐week, study of low‐dose extended‐release methylphenidate in adults with attention‐deficit/hyperactivity disorderEur Arch Psychiatry Clin Neurosci2009259212012919165529
   PubMed Web of Science ®Google Scholar
• BiedermanJMickESurmanCA randomized, 3‐phase, 34‐week, double‐blind, long‐term efficacy study of osmotic‐release oral system‐methylphenidate in adults with attention‐deficit/hyperactivity disorderJ Clin Psychopharmacol201030554955320814332
   PubMed Web of Science ®Google Scholar
• Sonuga‐BarkeEJCoghillDWigalTDeBackerMSwansonJAdverse reactions to methylphenidate treatment for attention‐deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom controlJ Child Adolesc Psychopharmacol200919668369020035586
   PubMed Web of Science ®Google Scholar
• ZhangHDuMZhuangSImpact of long‐term treatment of methylphenidate on height and weight of school age children with ADHDNeuropediatrics2010412555920799150
   PubMed Web of Science ®Google Scholar
• ConnersCKCasatCDGualtieriCTBupropion hydrochloride in attention deficit disorder with hyperactivityJ Am Acad Child Adolesc Psychiatry19963510131413218885585
   PubMed Web of Science ®Google Scholar
• ManeetonNManeetonBSrisurapanontMMartinSDBupropion for adults with attention‐deficit hyperactivity disorder: meta‐analysis of randomized, placebo‐controlled trialsPsychiatry Clin Neurosci201165761161722176279
   PubMed Web of Science ®Google Scholar
• BarrickmanLLPerryPJAllenAJBupropion versus methylphenidate in the treatment of attention‐deficit hyperactivity disorderJ Am Acad Child Adolesc Psychiatry19953456496577775360
   PubMed Web of Science ®Google Scholar
• KupermanSPerryPJGaffneyGRBupropion SR vs methylphenidate vs placebo for attention deficit hyperactivity disorder in adultsAnn Clin Psychiatry200113312913411791949
   PubMedGoogle Scholar
• LevinFREvansSMBrooksDJKalbagASGarawiFNunesEVTreatment of methadone‐maintained patients with adult ADHD: double‐blind comparison of methylphenidate, bupropion and placeboDrug Alcohol Depend200681213714816102908
   PubMed Web of Science ®Google Scholar
• JafariniaMMohammadiMRModabberniaABupropion versus methylphenidate in the treatment of children with attention‐deficit/hyperactivity disorder: randomized double‐blind studyHum Psychopharmacol201227441141822806822
   PubMed Web of Science ®Google Scholar
• SorokoFEMehtaNBMaxwellRAFerrisRMSchroederDHBupropion hydrochloride ((+/−) alpha‐t‐butylamino‐3‐chloropropiophenone HCl): a novel antidepressant agentJ Pharm Pharmacol1977291276777022628
   PubMed Web of Science ®Google Scholar
• BarisonFMassignanLRassegna di neuropsichiatria e scienze affini [Observations on neurotic depressions with reference to a combined serpasil‐ritalin treatment]Rass Neuropsichiatr1956105–6198209 Italian13494754
   PubMedGoogle Scholar
• HigginsJPTAltmanDGAssessing risk of bias in included studiesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011)The Cochrane Collaboration2009 Available from: http://www.cochrane-handbook.orgAccessed June 6, 2014
   Google Scholar
• CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 12 new‐generation antidepressants: a multiple‐treatments meta‐analysisLancet2009373966574675819185342
   PubMed Web of Science ®Google Scholar
• PapakostasGITolerability of modern antidepressantsJ Clin Psychiatry200869Suppl E181318494538
   PubMed Web of Science ®Google Scholar
• WiebeNVandermeerBPlattRWKlassenTPMoherDBarrowmanNJA systematic review identifies a lack of standardization in methods for handling missing variance dataJ Clin Epidemiol200659434235316549255
   PubMed Web of Science ®Google Scholar
• SterneJACEggerMMoherDAddressing reporting biasesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011)The Cochrane Collaboration2009 Available from: http://www.cochrane-handbook.orgAccessed June 6, 2014
   Google Scholar
• LoneyJMilichRHyperactivity, inattention, and aggression in clinical practiceWolraichMRouthDKAdvances in developmental and behavioral pediatricsGreenwich, CTJAI1982113147
   Google Scholar
• DupaulGJPowerTJAnastopoulosADReidRADHD Rating Scale—IV: Checklists, norms, and clinical interpretationNew YorkGuilford Press1998
   Google Scholar
• LeeJGrizenkoNBhatVSenguptaSPolotskaiaAJooberRRelation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHDBMC Psychiatry2011117021510895
   PubMed Web of Science ®Google Scholar
• WilensTEAdlerLAAdamsJMisuse and diversion of stimulants prescribed for ADHD: a systematic review of the literatureJ Am Acad Child Adolesc Psychiatry2008471213118174822
   PubMed Web of Science ®Google Scholar
• SembowerMAErtischekMDBuchholtzCDasguptaNSchnollSHSurveillance of diversion and nonmedical use of extended‐release prescription amphetamine and oral methylphenidate in the United StatesJ Addict Dis2013321263823480245
   PubMed Web of Science ®Google Scholar
• BiedermanJBaldessariniRJWrightVKneeDHarmatzJSA double‐blind placebo controlled study of desipramine in the treatment of ADD: I. EfficacyJ Am Acad Child Adolesc Psychiatry19892857777842676967
   PubMed Web of Science ®Google Scholar
• SingerHSBrownJQuaskeySRosenbergLAMellitsEDDencklaMBThe treatment of attention‐deficit hyperactivity disorder in Tourette’s syndrome: a double‐blind placebo‐controlled study with clonidine and desipraminePediatrics199595174817770313
   PubMed Web of Science ®Google Scholar
• WilensTEBiedermanJPrinceJSix‐week, double‐blind, placebo‐controlled study of desipramine for adult attention deficit hyperactivity disorderAm J Psychiatry19961539114711538780417
   PubMed Web of Science ®Google Scholar
• SpencerTBiedermanJCoffeyBA double‐blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention‐deficit/hyperactivity disorderArch Gen Psychiatry200259764965612090818
   PubMed Web of Science ®Google Scholar
• RiddleMAGellerBRyanNAnother sudden death in a child treated with desipramineJ Am Acad Child Adolesc Psychiatry19933247927978340300
   PubMed Web of Science ®Google Scholar
• PatakiCSCarlsonGAKellyKLRapportMDBiancanielloTMSide effects of methylphenidate and desipramine alone and in combination in childrenJ Am Acad Child Adolesc Psychiatry1993325106510728407753
   PubMed Web of Science ®Google Scholar
• RatnerSLaorNBronsteinYWeizmanATorenPSix‐week open‐label reboxetine treatment in children and adolescents with attention‐deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200544542843315843764
   PubMed Web of Science ®Google Scholar
• ArabgolFPanaghiLHebraniPReboxetine versus methylphenidate in treatment of children and adolescents with attention deficit‐hyperactivity disorderEur Child Adolesc Psychiatry2009181535918563471
   PubMed Web of Science ®Google Scholar
• RiahiFTehrani‐DoostMShahrivarZAlaghband‐RadJEfficacy of reboxetine in adults with attention‐deficit/hyperactivity disorder: a randomized, placebo‐controlled clinical trialHum Psychopharmacol2010257–857057621312292
   PubMed Web of Science ®Google Scholar
• ZarinaraARMohammadiMRHazratiNVenlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trialHum Psychopharmacol2010257–853053520860068
   PubMed Web of Science ®Google Scholar
• AmiriSFarhangSGhoreishizadehMAMalekAMohammadzadehSDouble‐blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorderHum Psychopharmacol2012271768122252909
   PubMed Web of Science ®Google Scholar
• KratochvilCJHeiligensteinJHDittmannRAtomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open‐label trialJ Am Acad Child Adolesc Psychiatry200241777678412108801
   PubMed Web of Science ®Google Scholar
• OvertoomCCVerbatenMNKemnerCEffects of methylphenidate, desipramine, and L‐dopa on attention and inhibition in children with attention deficit hyperactivity disorderBehav Brain Res1720031451–271514529800
   PubMed Web of Science ®Google Scholar
• SimmlerLDWandelerRLiechtiMEBupropion, methylphenidate, and 3,4‐methylenedioxypyrovalerone antagonize methamphetamine‐induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependenceBMC Res Notes2013622023734766
   PubMedGoogle Scholar
• NieuwstratenCEDolovichLRBupropion versus selective serotonin‐reuptake inhibitors for treatment of depressionAnn Pharmacother200135121608161311793630
   PubMed Web of Science ®Google Scholar